CLINICAL_TRIALS
trial_result
· 2021-09-24
Clinical Trial Update: Safety Study of Hepatitis E Vaccine (HEV239) [Phase 1]
Summary
Phase 1 safety trial of the Hepatitis E vaccine HEV239 has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis E, Immunisation | Phase 1 | Status: COMPLETED | Results posted: 2021-09-24